AdaptHealth (AHCO) Depreciation & Amortization (CF) (2021 - 2026)

AdaptHealth has reported Depreciation & Amortization (CF) for 6 years, with the latest figure at $114.8 million in Q2 2026.

• On a quarterly basis, Depreciation & Amortization (CF) rose 32.03% year-over-year to $114.8 million in Q2 2026; TTM through Jun 2026 was $416.5 million, a 14.86% increase from a year earlier, with the FY2025 full-year figure at $381.9 million, up 4.54% from the prior year.
• Depreciation & Amortization (CF) was $114.8 million for Q2 2026 at AdaptHealth, up from $106.5 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $114.8 million in Q2 2026, with the low at $77.0 million in Q1 2022.
• Average Depreciation & Amortization (CF) over 5 years is $94.3 million, with a median of $93.3 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) surged 63.18% in 2022, then slipped 9.75% in 2023.
• Over 5 years, Depreciation & Amortization (CF) stood at $102.3 million in 2022, then fell by 9.75% to $92.4 million in 2023, then declined by 1.98% to $90.5 million in 2024, then gained by 7.7% to $97.5 million in 2025, then gained by 17.7% to $114.8 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $114.8 million (Q2 2026), $106.5 million (Q1 2026), and $97.5 million (Q4 2025), per Business Quant data.